Nitric oxide-induced carbonylation of Bcl-2, GAPDH and ANT precedes apoptotic events in insulin-secreting RINm5F cells

Experimental Cell Research

Volumn 293, Issue 1, 2004, Pages 22-30

  Cahuana, Gladys M ^a   Tejedo, Juan R ^a   Jiménez, Juan ^a   Ramírez, Remedios ^a   Sobrino, Francisco ^a   Bedoya, Francisco J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

ANT; Apoptosis; Bcl 2; Beta cells; Carbonylation; GAPDH; NO

Indexed keywords

3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; ADENINE NUCLEOTIDE; ADENINE NUCLEOTIDE TRANSLOCASE; AMINOGUANIDINE; DIETHYLTOLUAMIDE; DNA FRAGMENT; DRUG DERIVATIVE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; LINSIDOMINE; MOLSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROTEIN BCL 2; PYRIDOXAMINE; SCAVENGER; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBONYLATION; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; INSULIN RELEASE; INSULINOMA; KINETICS; LIPID PEROXIDATION; METABOLISM; MITOCHONDRION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

FORMICIDAE;

EID: 0346059418     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.10.004     Document Type: Article

References (48)

1. Kurrer M.O., Pakala S.V., Hanson H.L., Katz J.D. Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. U. S. A. 94:1997;213-218.
2. Mauricio D., Mandrup-Poulsen T. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes. 47:1998;1537-1543.
3. Pipeleers D., Hoorens A., Marichal-Pipeleers M., Van de Casteele M., Bouwens L., Ling Z. Role of pancreatic β-cells in the process of β-cell death. Diabetes. 50:2001;S52-S57.
4. Mandrup-Poulsen T. Role of IL-1 in the pathogenesis of IDDM. Diabetologia. 39:1996;1005-1029.
5. Saldeen J., Tillmar L., Karlsson E., Welsh N. Nicotinamide- and caspase-mediated inhibition of poly(ADP-ribose)polymerase are associated with p53-independent cell cycle (G2) arrest and apoptosis. Mol. Cell. Biochem. 243:2003;113-122.
6. Barbu A., Welsh N., Saldeen J. Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential (Deltapsi(m)) in pancreatic RINm5F cells: prevention by Bcl-2. Mol. Cell. Endocrinol. 190:2002;75-82.
7. Tejedo J., Bernabé J.C., Ramírez R., Sobrino F., Bedoya F.J. NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett. 459:1999;238-243.
8. Breitschopf K., Haendeler J., Malchow P., Zeiher A.M., Dimmeler S. Posttraslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol. Cell. Biol. 20:2000;1886-1896.
9. Yang Y., Yu X. Regulation of apoptosis: the ubiquitous way. FASEB J. 17:2003;790-799.
10. Grune T., Shringarpure R., Sitte N., Davies K. Age-related changes in protein oxidation and proteolysis in mammalian cells. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 56:2001;B459-B467.
11. Ciechanover A., Scwartz A.L. The ubiquitin-proteasome pathway: the complexity and myriad functions of protein death. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2727-2730.
12. Sitte N., Merker K., Grune T. Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts. FEBS Lett. 440:1998;399-402.
13. Ullrich O., Grune T. Proteosomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells. Free Radical Biol. Med. 31:2001;887-893.
14. Fujino T., Watanabe K., Beppu M., Kikugawa K., Yasuda H. Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochim. Biophys. Acta. 1478:2000;102-112.
15. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., Milzani A. Protein carbonylation in human diseases. Trends Mol. Med. 9:2003;169-176.
16. Dimmeler S., Breitschopf K., Haendeler J., Zeiher A.M. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189:1999;1815-1822.
17. van Loo G., Saelens X., Gurp M., MacFarlene M., Martin S.J., Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9:2002;1024-1031.
18. Mazzola J.L., Sirover M.A. Alteration of nuclear glyceraldehyde-3- phosphate dehydrogenase structure in Huntington's disease fibroblast. Brain Res. Mol. Brain Res. 100:2002;95-101.
19. Berry M.D., Boulton A.A. Glyceraldehyde-3-phosphate dehydrogenase and apoptosis. J. Neurosci. Res. 60:2000;150-154.
20. Sawa A., Khan A.A., Hester L.D., Snyder S.H. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11669-11674.
21. Dastor Z., Dreyer J.L. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J. Cell Sci. 114:2001;1643-1653.
22. Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra and intermolecular cross-linking reaction. J. Biol. Chem. 268:1993;6388-6393.
23. Patel R.P., McAndrew J., Sellak H., White C.R., Jo H., Freeman B.A., Darley-Usmar V.M. Biological aspects of reactive nitrogen species. Biochim. Biophys. Acta. 1411:1999;385-400.
24. Xie K., Wang Y., Huang S., Xu L., Bielenberg D., Salas T., McConkey D.J., Jiang W., Fidler I.J. Nitric oxide mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2. Oncogene. 15:1997;771-779.
25. Brockhaus F., Brune B. U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation. Exp. Cell Res. 238:1998;33-41.
26. Kirsch D.G., Doseff A., Nelson Chau B., Lim D.S., de Souza-Pinto N.C., Hansford R., Kastan M.B., Lazebnik Y.A., Hardwick J.M. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. 274:1999;21155-212161.
27. L induced in activated macrophages. J. Immunol. 160:1998;2590-2596.
28. Desagher S., Martinou J.C. Mitochondria as central control point of apoptosis. Trends Cell Biol. 10:2000;369-377.
29. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 495:2000;12-15.
30. Parker M.A., Murphy M.P. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation. Eur. J. Biochem. 234:1995;231-239.
31. Balakirev M.Y., Khramtsov V.V., Zimmer G. Modulation of the mitochondrial permeability transition by nitric oxide. Eur. J. Biochem. 246:1997;710-718.
32. Hortelano S., Dallaporta B., Zamzami N., Hirsch T., Susin S.A., Marzo I., Bosca L., Kroemer G. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett. 410:1997;373-377.
33. Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radical Biol. Med. 26:1999;463-471.
34. Kristal B.S., Park B.K., Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271:1996;6033-6038.
35. Yan L.J., Sohal R.S. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12896-12901.
36. Giron-Calle J., Zwizinski C.W., Schmid H.O. Peroxidative damage to cardiac mitochondria: II. Immunological analysis of modified adenine nucleotide translocase. Arch. Biochem. Biophys. 315:1994;1-7.
37. Costantini P., Belzacq A.S., La Vieira H., Larochette N., de Pablo M.A., Zamzami N., Susin S.A., Brenner C., Kroemer G. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene. 19:2000;307-314.
38. La Vieira H., Belzacq A.S., Haouzi D., Bernassola F., Cohen I., Jacotot E., Ferri F., El Hamel C., Bartle L.M., Melino G., Brenner C., Goldmacher V., Kroemer G. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene. 20:2001;4305-4316.
39. Cahuana G.M., Tejedo J.R., Jiménez J., Ramírez R., Sobrino F., Bedoya F.J. Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of NO in insulin secreting RINm5F cells. Biochem. Pharmacol. 66:2003;1963-1971.
40. Al-Abed Y., Bucala R. Efficient scavenging of fatty acid oxidation products by aminoguanidine. Chem. Res. Toxicol. 10:1997;875-879.
41. Onorato J.M., Jenkins A.J., Thorpe S.R., Baynes J.W. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipooxidation reactions. Mechanism of action of pyridoxamine. J. Biol. Chem. 275:2000;21177-21184.
42. Voziyan P.A., Metz T.O., Baynes J.W., Hudson B.G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 277:2002;3397-3403.
43. Gow A.J., Ischiropoulos H. Nitric oxide chemistry and cellular signaling. J. Cell. Physiol. 187:2001;277-282.
44. Padgett C.M., Whorton A.R. S-Nitrosoglutathione reversible inhibits GAPDH by S-nitrosylation. Am. J. Physiol. 269:1995;C739-C749.
45. Padgett C.M., Whorton A.R. Glutathione redox cycle regulates nitric oxide-mediated GAPDH inhibition. Am. J. Physiol. 272:1997;C99-C108.
46. Veluthakal R., Khan I., Tannous M., Kowluru A. Functional inactivation by interleukin 1β of glyceraldehyde-3-phosphate dehydrogenase in insulin-secreting cells. Apoptosis. 7:2002;241-246.
47. Dimmeler S., Ankarcrona M., Nicotera P., Brüne B. Exogenous nitric oxide (NO) generation or IL-1β-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J. Immunol. 150:1993;2964-2971.
48. Dastoor Z., Dreyer J.L. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J. Cell Sci. 114:2001;1643-1653.